Oric Pharmaceuticals, Inc.
SEC CIK 1796280 · ORIC · last insider filing 2026-02-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Heyman Richard A. | Director | filed 2020 - 2026 |
| Hoerter Steven L. | Director | filed 2021 - 2026 |
| Kunkel Lori Anne | Director | filed 2020 - 2026 |
| Dier Mardi | Director | filed 2020 - 2026 |
| Chacko Jacob | Director · President and CEO | filed 2020 - 2026 |
| You Angie | Director | filed 2021 - 2026 |
| Svennilson Peter | Director | filed 2020 - 2021 |
| Gordon Carl L | Director | filed 2020 - 2021 |
| Scheller Richard H | Director | filed 2020 - 2021 |
| Orbimed Advisors LLC | Director | filed 2020 - 2021 |
| Orbimed Capital GP VI LLC | Director | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Piscitelli Dominic | Chief Financial Officer | filed 2020 - 2026 |
| Multani Pratik S | Chief Medical Officer | filed 2020 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.